Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.

Blevins TP, Yu Y, Belshe RB, Bellamy AR, Morrison LA.

PLoS One. 2019 Apr 4;14(4):e0214467. doi: 10.1371/journal.pone.0214467. eCollection 2019.

2.

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults.

Hoft DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00414-16. doi: 10.1128/CVI.00414-16. Print 2017 Jan.

3.

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.

Hoft DF, Lottenbach K, Goll JB, Hill H, Winokur PL, Patel SM, Brady RC, Chen WH, Edwards K, Creech CB, Frey SE, Blevins TP, Salomon R, Belshe RB.

J Infect Dis. 2016 Oct 1;214(7):1020-9. doi: 10.1093/infdis/jiw310. Epub 2016 Jul 20.

4.

Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.

Baccari A, Cooney M, Blevins TP, Morrison LA, Larson S, Skoberne M, Belshe RB, Flechtner JB, Long D.

Vaccine. 2016 Jul 19;34(33):3901-6. doi: 10.1016/j.vaccine.2016.05.033. Epub 2016 Jun 15.

PMID:
27265458
5.

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

Blevins TP, Mitchell MC, Korom M, Wang H, Yu Y, Morrison LA, Belshe RB.

PLoS One. 2015 Dec 14;10(12):e0144738. doi: 10.1371/journal.pone.0144738. eCollection 2015.

6.

Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination.

Thakar J, Mohanty S, West AP, Joshi SR, Ueda I, Wilson J, Meng H, Blevins TP, Tsang S, Trentalange M, Siconolfi B, Park K, Gill TM, Belshe RB, Kaech SM, Shadel GS, Kleinstein SH, Shaw AC.

Aging (Albany NY). 2015 Jan;7(1):38-52.

7.

Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults.

Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP, Siconolfi B, Meng H, Devine L, Raddassi K, Tsang S, Belshe RB, Hafler DA, Kaech SM, Kleinstein SH, Trentalange M, Allore HG, Shaw AC.

J Infect Dis. 2015 Apr 1;211(7):1174-84. doi: 10.1093/infdis/jiu573. Epub 2014 Nov 2.

8.

A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.

Frey SE, Lottenbach KR, Hill H, Blevins TP, Yu Y, Zhang Y, Brenneman KE, Kelly-Aehle SM, McDonald C, Jansen A, Curtiss R 3rd.

Vaccine. 2013 Oct 1;31(42):4874-80. doi: 10.1016/j.vaccine.2013.07.049. Epub 2013 Aug 3.

PMID:
23916987
9.

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.

Newman FK, Frey SE, Blevins TP, Mandava M, Bonifacio A Jr, Yan L, Belshe RB.

J Clin Microbiol. 2003 Jul;41(7):3154-7.

10.

Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.

Newman FK, Frey SE, Blevins TP, Yan L, Belshe RB.

J Infect Dis. 2003 Apr 15;187(8):1319-22. Epub 2003 Apr 2.

PMID:
12696013

Supplemental Content

Loading ...
Support Center